Caliber’s Post

Congratulations to the 5 Most Trusted & Liked Companies on the OMX C25 in 2023 🚀 1️⃣ Novo Nordisk once again has the best corporate reputation among companies listed on Denmark’s OMX C25 index. The pharmaceuticals giant looks to “transform bold ideas into life-saving and preventive medicines” — and 2023 was no exception for it, as the momentum behind two blockbuster drugs, Wegovy and Ozempic, was unstoppable. Novo Nordisk was also recognized as the world’s best company to work for, a place where talent thrives and innovation flourishes. 2️⃣ Second place again goes to Novozymes, a global leader in biosolutions. Its mission is to “help grow businesses, safeguard the planet’s resources and make lives better”. Its products are used in both consumer products (like household care and human health) and industrial and agricultural products (like animal health and carbon capture). Last year also saw the regulatory approval of its proposed merger with Chr. Hansen. 3️⃣ Third spot once again goes to Chr. Hansen, a biosciences company that looks to “drive positive change through our sustainable microbial solutions and enable a future that values nature as the foundation of a healthy society”. As that includes sustainable agriculture, better food and healthier living, it’s understandable why Chr. Hansen continues to have a strong reputation among stakeholders. 4️⃣ Coloplast takes fourth place again this year, its high position a reflection of its commitment to improving the lives of people with “intimate healthcare” needs — meaning products and services that make life easier for people with “very personal and private medical conditions”. Once again, stakeholders appreciate the company’s dedication to innovation and customer well-being. 5️⃣ Rounding out the top five is energy company Vestas. Its vision is to become “the global leader in sustainable energy solutions”. Wind energy is the company’s heritage and core competence: it designs, manufactures and installs wind and hybrid energy projects all over the world — a commitment to sustainable energy that helps position Vestas among Denmark’s five most trusted and liked companies once again. 📥 To see where all the OMX C25 companies rank — or to explore the results from seven other countries — download the 2023 Trust & Like Score Rankings now. #OMXC25 #novonordisk #novozymes #chrhansen #coloplast #vestas

LogiPharma 2024 kicks off today in Lyon. Our delegates Alexander Nuyken, Emma Kramer, Benoit Lamour de Caslou, Matthijs Weeink and Ben Horner are on the ground and looking forward to meeting with supply chain leaders to explore how to create greener, more agile and more innovative networks in an era of disruption and transformation. Want to discuss the latest industry trends and how to enhance your location strategy? Schedule a chat with the team → https://co.jll/3WhuGkj #lifesciences #realestate #supplychain

Zurich airport – on my way to Barcelona for the Gartner Supply Chain Symposium #gartnersc   This year is going to be big… and I am particularly excited as we are introducing new Controlant technology on the journey to eliminate waste in pharma supply chains – to get more medicines to more patients – at higher quality, reliability and predictability, with shorter time to market, lower cost and reduce inventories.   And we get the chance to do it with the esteemed crowd of Life Science Supply Chain executives and analysts at #Gartnersc   Real-time decision execution is a priority for 96% of Supply Chain Executives, but only 7% have those capabilities in place, according to Gartner. We are ready to present how it is done in Pharma Supply Chains – with an intelligent platform at the heart – and fully GxP compliant across platform, applications, devices and services.   If you are at the #Gartnersc conference and curious to meet thought leaders at a remarkable setting – reach out to join the Controlant event Monday evening – for the usual Controlant vibe of fun, interesting discussions, networking and some great food and drinks.   See you there…    #supplychain #zerowastesupplychain #realtimevisibility #realtimedecisionmaking #innovation #pharmasupplychain #lifescience

The global #ArtificialBoneMarket is set to grow by USD 170.77 million at a CAGR of 8.5% between 2022 and 2027. Increasing #awareness, advanced #MedicalTreatments, and rapid technological advancements are driving this growth. Discover the segmented market and the significant contribution of #NorthAmerica. Read more about this market: https://lnkd.in/gAigFfRV #MedicalInnovations #MarketGrowth